| 证券代码： | 301229 | 证券简称： | 纽泰格 | 公告编号： | 2025-107 | | --- | --- | --- | --- | --- | --- | | 债券代码： | 123201 | 债券简称： | 纽泰转债 | | | 江苏纽泰格科技集团股份有限公司 关于对外投资设立全资子公司与孙公司的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 江苏纽泰格科技集团股份有限公司（以下简称"公司"）于 2025 年 11 月 7 日召开第 三届董事会第三十二次会议，审议通过了《关于对外投资设立全资子公司与孙公司的议 案》。现将相关事宜具体情况公告如下： 二、对外投资设立全资子公司的基本情况 1、公司名称：江苏纽泰格机器人科技有限公司 2、公司类型：有限责任公司 3、注册地址：江苏省淮安市 4、注册资本：10,000 万元 一、对外投资概述 1、公司计划使用自有资金 10,000 万元对外投资设立全资子公司江苏纽泰格机器人 科技有限公司（以下简称"江苏纽泰格机器人"），并通过该全资子公司出资 500 万元对 外投资设立全资孙公司上海纽泰 ...

证券代码： 301229 证券简称： 纽泰格 公告编号： 2025-106 债券代码： 123201 债券简称： 纽泰转债 江苏纽泰格科技集团股份有限公司 第三届董事会第三十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 2、本次会议于 2025 年 11 月 7 日在公司会议室以现场与通讯相结合的方式召开。 3、本次会议应出席董事 7 人，实际出席董事 7 人。其中现场出席会议的董事 5 人， 董事杨勤法、张卫平以通讯方式参会。 4、本次会议由董事长戈浩勇先生主持，公司监事、高级管理人员列席了本次会议。 5、本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法律、法规 和《江苏纽泰格科技集团股份有限公司章程》的有关规定。 二、董事会会议审议情况 审议通过《关于对外投资设立全资子公司与孙公司的议案》 经审议，董事会认为：公司对外投资设立全资子公司与全资孙公司，从事具身智能 机器人、工业机器人、服务消费机器人及相关零部件产品的研发、生产及销售，符合公 司战略发展规划和经营需要，有利于公司把握机器人行业发展机遇， ...

Core Viewpoint - Nutaige experienced a decline of 0.93% on November 6, with a trading volume of 56.55 million yuan, indicating a challenging market environment for the company [1]. Financing Summary - On November 6, Nutaige had a financing buy-in amount of 3.42 million yuan and a financing repayment of 7.60 million yuan, resulting in a net financing outflow of 4.18 million yuan [1]. - The total financing and securities balance for Nutaige as of November 6 is 113 million yuan, which accounts for 2.93% of its circulating market value, indicating a high level compared to the past year [1]. - Nutaige's margin trading showed no short selling or repayment on November 6, with a margin balance of 0, also reflecting a high level compared to the past year [1]. Business Performance - As of September 30, Nutaige reported a total of 11,300 shareholders, an increase of 2.86% from the previous period, while the average circulating shares per person decreased by 1.86% to 9,657 shares [2]. - For the period from January to September 2025, Nutaige achieved an operating revenue of 788 million yuan, representing a year-on-year growth of 12.07%, while the net profit attributable to shareholders decreased by 32.07% to 31.57 million yuan [2]. Dividend Information - Since its A-share listing, Nutaige has distributed a total of 46.21 million yuan in dividends, with 38.21 million yuan distributed over the past three years [3].

Core Viewpoint - The company, Nutaeg, has signed a strategic cooperation agreement with BASF (China) Ltd. to explore opportunities in the robotics and automotive industries, focusing on advanced material solutions [1] Group 1: Strategic Cooperation - The agreement was signed in October 2025, indicating a long-term partnership aimed at leveraging each company's strengths [1] - The collaboration will integrate BASF's leading technology in advanced materials with Nutaeg's expertise in product application development and advanced manufacturing [1] Group 2: Industry Focus - Both companies are optimistic about the development prospects in the robotics industry, including embodied intelligence and commercial robots, as well as the automotive sector [1] - The partnership aims to promote innovation in lightweight, high-strength, and high-precision components for both industries [1] Group 3: Current Development Stage - Nutaeg is currently in the early stages of developing robotic components, with further progress to be announced in future company updates [1] - Investors are advised to be aware of the uncertainties associated with product development and market expansion [1]

Core Viewpoint - The company Nuotai Ge (301229) has signed a strategic cooperation agreement with BASF (China) Co., Ltd. to explore advanced material solutions for the robotics and automotive industries, focusing on lightweight, high-strength, and high-precision components [1] Group 1: Strategic Cooperation - The agreement was signed on October 2025, indicating a long-term vision for collaboration between the two companies [1] - Both companies recognize the growth potential in the robotics sector, including embodied intelligence and commercial robotics, as well as the automotive industry [1] Group 2: Development Focus - The collaboration aims to integrate BASF's leading technology in advanced materials with Nuotai Ge's expertise in product application development and advanced manufacturing [1] - The company is currently in the early stages of developing robotic components, with further progress to be announced in future communications [1]

Core Viewpoint - BASF and Jiangsu New Times Technology Group Co., Ltd. signed a strategic cooperation agreement to promote material innovation in the robotics and automotive industries, leveraging BASF's expertise in advanced materials and New Times' capabilities in product development and manufacturing [1]. Group 1: Strategic Partnership - The strategic cooperation agreement was officially signed on October 20 in Shanghai [1]. - The partnership aims to integrate BASF's leading technology in advanced materials with New Times' expertise in product application development and advanced manufacturing [1]. - Both companies are optimistic about the development prospects in the robotics industry, including embodied intelligence and commercial robots, as well as the automotive sector [1]. Group 2: Development Focus - The collaboration will focus on developing advanced material solutions for the robotics and automotive industries, emphasizing lightweight, high-strength, and high-precision components [1]. - Currently, New Times is in the early stages of developing robotic components, with further progress to be announced in future company updates [1].

Group 1 - Yuheng Pharmaceutical plans to resolve a debt dispute with Qingdao Pusheng Puli Enterprise Management Center regarding the equity transfer payment for Yuheng Biotechnology, which involves a 42.12% stake valued at 117.6 million yuan [1] - Due to Pusheng Puli's failure to pay the agreed amount on time, Yuheng Pharmaceutical initiated legal proceedings in April 2024, which are currently in the execution phase, with no payments received yet [1] - Pusheng Puli intends to transfer 20.64% of its stake in Yuheng Biotechnology to Youpeng Biotechnology (Hainan) Co., Ltd., using the proceeds to settle its debt to Yuheng Pharmaceutical [1] Group 2 - November 4 marks the last conversion day for "Nuitai Convertible Bonds," allowing investors to convert their bonds before market close [1] - After November 4, any unconverted "Nuitai Convertible Bonds" will be forcibly redeemed at a price of 100.36 yuan per bond, potentially leading to losses for investors [1]

| 证券代码： | 301229 | 证券简称： | 纽泰格 | 公告编号： | 2025-104 | | --- | --- | --- | --- | --- | --- | | 债券代码： | 123201 | 债券简称： | 纽泰转债 | | | 江苏纽泰格科技集团股份有限公司 关于纽泰转债即将停止转股暨赎回前 1、需要债券持有人自行操作转股，不会自动转股。 2、2025 年 10 月 30 日收市后"纽泰转债"已停止交易。 3、最后转股日：2025 年 11 月 4 日。 2025 年 11 月 4 日为"纽泰转债"最后一个转股日，当日收市前，持有"纽泰转债"的 投资者仍可进行转股。2025 年 11 月 4 日收市后，仍未实施转股的"纽泰转债"将停止转股， 剩余"纽泰转债"将按照 100.36 元/张（债券面值加当期应计利息，当期年利率为 1.00%，且 当期利息含税）的价格强制赎回。若被强制赎回，投资者可能面临损失，敬请投资者注意投 资风险。 截至 2025 年 11 月 4 日上午收市后，距离"纽泰转债"停止转股并赎回仅剩半个交易日。 4、债券持有人若转股，需开通创业板交易权限。 投资者不符合 ...

| 证券代码： | 301229 | 证券简称： | 纽泰格 | 公告编号： | 2025-103 | | --- | --- | --- | --- | --- | --- | | 债券代码： | 123201 | 债券简称： | 纽泰转债 | | | 江苏纽泰格科技集团股份有限公司 关于纽泰转债即将停止转股暨赎回前 最后一个交易日的重要提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要提示： 1、需要债券持有人自行操作转股，不会自动转股。 2、2025 年 10 月 30 日收市后"纽泰转债"已停止交易。 3、最后转股日：2025 年 11 月 4 日。 2025 年 11 月 4 日为"纽泰转债"最后一个转股日，当日收市前，持有"纽泰转债"的 投资者仍可进行转股。2025 年 11 月 4 日收市后，仍未实施转股的"纽泰转债"将停止转股， 剩余"纽泰转债"将按照 100.36 元/张（债券面值加当期应计利息，当期年利率为 1.00%，且 当期利息含税）的价格强制赎回。若被强制赎回，投资者可能面临损失，敬请投资者注意投 资风险。 截至 202 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要提示： 1、需要债券持有人自行操作转股，不会自动转股。 2、2025 年 10 月 30 日收市后"纽泰转债"已停止交易。 3、最后转股日：2025 年 11 月 4 日。 | 证券代码： | 301229 | 证券简称： | 纽泰格 | 公告编号： | 2025-101 | | --- | --- | --- | --- | --- | --- | | 债券代码： | 123201 | 债券简称： | 纽泰转债 | | | 江苏纽泰格科技集团股份有限公司 关于纽泰转债即将停止转股暨赎回实施的重要提示性公告 2025 年 11 月 4 日为"纽泰转债"最后一个转股日，当日收市前，持有"纽泰转债"的 投资者仍可进行转股。2025 年 11 月 4 日收市后，仍未实施转股的"纽泰转债"将停止转股， 剩余"纽泰转债"将按照 100.36 元/张（债券面值加当期应计利息，当期年利率为 1.00%，且 当期利息含税）的价格强制赎回。若被强制赎回，投资者可能面临损失，敬请投资者注意投 资风险。 截至 2025 年 10 ...